Genmab more than doubles Q1 sales

An unusual combination of events drove revenue at Genmab A/S up by DKK 430 million to DKK 681 million (€91.4 million) in the first quarter, for an increase of 171% compared with a year earlier. Operating income consequently rose to DKK 324 million from DKK 46 million the previous year.

Full text available to subscribers only. Click here for information on subscribing to MedNous.